A study of 243 patients with SS showed that, regardless of tissue type, the prognosis of SS with SYT‐SSX1 fusion transcripts was worse than that of SYT‐SSX2 fusion transcriptions. The gene discussed is SSX2; the disease is synovial sarcoma.